|
|
| | Pregn-5-en-3-ol,(3)-(9CI) Basic information |
| Product Name: | Pregn-5-en-3-ol,(3)-(9CI) | | Synonyms: | Pregn-5-en-3-ol,(3)-(9CI);3β-Hydroxypregn-5-ene;Δ5-Pregnen-3β-ol;3beta-Hydroxypregn-5-ene;(3S,8S,9S,10R,13R,14S,17S)-17-ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3β)-Pregn-5-en-3-OL;Pregn-5-en-3β-ol;(3β)-Prostaglandin-5-ene-3-ol | | CAS: | 2862-58-0 | | MF: | C21H34O | | MW: | 302.49406 | | EINECS: | | | Product Categories: | | | Mol File: | 2862-58-0.mol |  |
| | Pregn-5-en-3-ol,(3)-(9CI) Chemical Properties |
| form | Solid | | color | White to off-white |
| | Pregn-5-en-3-ol,(3)-(9CI) Usage And Synthesis |
| Uses | Pregn-5-en-3β-ol, a steroid compound, when formulated as the biscarboxylic acid hemiesters along with androst-5-en-3β-ol, serves as a potent positive allosteric modulator of NMDA (N-methyl-D-aspartate) receptors, making it applicable for research into psychiatric disorders[1]. | | Definition | ChEBI: 3beta-Hydroxypregn-5-ene is a corticosteroid hormone. | | References | [1] Marika Matousova, et al. Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability. Steroids. 2019 Jul:147:4-9. DOI:10.1016/j.steroids.2018.09.012 |
| | Pregn-5-en-3-ol,(3)-(9CI) Preparation Products And Raw materials |
|